BL
DGX icon

Balentine LLC’s Quest Diagnostics DGX Stock Holding History

Balentine LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,898
Closed -$385K – 631
2022
Q2 		$385K Buy
+2,898
New +$395K 0.01% 373
2020
Q3 		– Sell
-76
Closed -$9K – 327
2020
Q2 		$9K Buy
76
+62
+443% +$6.58K ﹤0.01% 573
2020
Q1 		$1K Buy
14
+2
+17% +$207 ﹤0.01% 608
2019
Q4 		$1K Buy
12
+6
+100% +$626 ﹤0.01% 561
2019
Q3 		$1K Hold
6
– – ﹤0.01% 672
2019
Q2 		$1K Buy
+6
New +$577 ﹤0.01% 685

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Balentine LLC's DGX Position: Q3 2022 in Review

Balentine LLC sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 2,898 shares — an estimated $385K sold.

Balentine LLC first reported a position in DGX in Q2 2019 and held it in 6 quarters. The position peaked at $385K in Q2 2022. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Balentine LLC reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Balentine LLC sold 2,898 Quest Diagnostics shares in Q3 2022, an estimated $385K.
  • Balentine LLC first reported a position in Quest Diagnostics in Q2 2019 and held it in 6 quarters.
  • Balentine LLC's Quest Diagnostics position peaked at $385K in Q2 2022.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Balentine LLC's 13F filing for Q3 2022, filed 26 Oct 2022.